Support & Communication Committee 

Dr. Mai Alalawi is a hematology/oncology clinical pharmacist. She completed her PharmD degree from King Abdulaziz University in 2018 with 1st-degree honors. In 2021, she graduated from the  International Pharmacy Practice Residency Program  (ASHP accredited) at Children’s Cancer Hospital Cairo (57357) and then she pursued her career in the oncology field and earned the Saudi board in Hematology/oncology clinical pharmacy after completing her training at King Abdulaziz Medical City- western region. Additionally, Mai is TOT-certified, and she has mentored students in research since she was an intern and led several research workshops and schools. Additionally, she is actively engaging in several projects related to healthcare and education. 

Dr. Mai’s area of interest includes pediatric oncology/hematology and bone marrow transplantation.

Aisha Alharbi is an Infectious Disease Clinical Pharmacist. She completed her PharmD from King Abdulaziz University with the 1st honorary degree in 2018. Following that, she completed her PGY1 Pharmacy Residency program at king Abdulaziz University Hospital and her PGY2 Pharmacy Residency in Infectious Disease from King Abdulaziz Medical City-Western Region. Aisha was awarded with several research awards during both her internship and residency. She participated in research teaching courses in Jeddah, Riyadh, and Medina. She also organized and supervised the 1st pharmacy research summer school that ended with training 25 students and conducting 5 different clinical research projects. Also, She have completed Training of Trainers (TOT) program on research methodology course, in collaboration with the Clinical Research Unit at King Abdul-Aziz University. Aisha have several research publications in prestigious journals and her research interests include infectious disease pharmacotherapy and antimicrobial stewardship.

Dr. Samiah Alsohimi is a Critical care clinical pharmacist specialist at king Fahd Armed Forces Hospital Jeddah. She received her PharmD degree from the College of Pharmacy at King Abdulaziz University in 2016. She started her career as pharmacist since 2017. Then, she completed her Saudi board Postgraduate Year 1 (PGY1) Pharmacy Residency. Subsequently, she earnd her Saudi board Postgraduate Year 2 (PGY2) Pharmacy Residency specializes in critical care pharmacotherapy. 

Dr.Alsohimi, an American board-certified specialist in critical care pharmacotherapy. Dr. Alsohimi, has several publications in peer-reviewed journals. Dr.Samiah published several research publications on critical care. Her current research areas of interest are critical care , infectious disease , cardiology,quality improvement , education and training.

Dr. Mashael AlFaifi is critical care clinical pharmacist at King Saud Medical City (KSMC). Dr. Mashael received her PharmD degree from Jazan University in 2018. Shortly after graduation, she joined and completed PGY-1 residency program at King Saud Medical City (KSMC) in (2021). Additionally, she has been certified by the American Board as a Pharmacotherapy Specialist.  In 2022, Dr.Mashael complete her PGY-2 in Critical care residency program at King Abdulaziz Medical City- National guard health affairs (KAMC-CR). 

Dr. Mashael developed an interest through many publications in research related to critical care and ID field. Her research areas of interest are; neuro critical care, burn and infectious disease.

Dr.Abdullah is an Assistant Professor of pharmacy practice at Shaqra University and Critical Care clinical pharmacist. Dr.Abdullah completed his PharmD in 2017 from Taif University. Then, he joined King Abdulaziz Medical City- National Guard Health Affairs as a PGY1 resident in 2018. After that, in 2021, he completed his PGY2 in critical care at KAMC-Ryiadh. 

Dr.Abdullah is a dual American board-certified specialist in pharmacotherapy and critical care. 

In 2022, he was selected as a board member and secretary/treasurer of the Critical Care Pharmacy Specialized Network (PSN) of The Saudi Society of Clinical Pharmacy (SSCP). Dr.Abdullah’s area of interest is Trauma, Burn, and research.

Dr. Rahaf Alqahtani, a clinical pharmacist specializing in critical care, works at King Abdulaziz Medical City in Riyadh (KAMC-RD). She earned her Doctor of Pharmacy degree from King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) in May 2019. Following that, she completed a Pharmacy Practice Residency (PGY-1) at KAMC-RD in 2021, followed by a Critical Care Residency (PGY-2) in 2022. 

Dr. Rahaf is board certified in pharmacotherapy and critical care. Additionally, she acts as a preceptor, guiding pharmacy residents and students during their critical care rotations at KAMC-RD.

Dr. Asma Alshehri is a Critical Care Clinical Pharmacist at Prince Sultan Military Medical City in Riyadh. Her professional journey in pharmacy began in 2018 after graduating from King Khalid University, where she promptly joined Prince Sultan Military Medical City (PSMMC) in the same year.

In 2021, Dr. Alshehri completed her Pharmacy Residency Program (PGY1) at Security Forces Hospital in Riyadh, followed by a PGY2 in Critical Care Specialty at National Guard Health Affairs, Riyadh, Saudi Arabia, in 2023. She is an American Board-Certified Pharmacotherapy specialist. 

Dr. Alshehri is actively engaged in various projects related to patient care and education, with several publications in the field of Intensive Care Unit (ICU) practices. Her interests include education, research, training, and graphic design.

Walaa A. Alshahrani recently graduated from King Saud bin Abdulaziz University for Health Sciences with a Doctor of Pharmacy degree. She is currently a licensed pharmacist.  

Walaa is passionate about her career and ensures ongoing professional development. She has several publications in different areas, including nephrology, oncology, and critical care. 

Her interests include research, clinical practice, digital health, volunteering, and graphic design.

Dr. Alaboud is Oncology/Hematology clinical pharmacist at the Ministry of National Guard Health Affairs in Jeddah (MNGHA-WR). Dr. Alaboud  earned her Doctor of Pharmacy PharmD degree from King AbdulAziz University in 2018. 

AffairsIn Nov 2022 Dr. Alaboud completed her Pharmacy Practice Resident (PGY-1) at Prince Mohammed bin Abdulaziz Hospital· In 2023, Dr. Alaboud  complete her PGY-2 in Oncology/Hematology residency program at King Abdulaziz Medical City- National Guard health affairs in Jeddah (MNGHA-WR). 

Dr. Alaboud is board certified in oncology pharmacy (BCOP) by the Board Certificate Of Oncology Pharmacy. Dr. Mashael developed an interest through many publications in research related to oncology/hematology and the ID field.

Dr. Marwah I Bin Abdulqader is a highly motivated pharmacy intern with a strong passion for innovative research, volunteering, public speaking, and promoting health awareness, all of which align with her professional goal of making meaningful contributions in the field. She consistently strives to exceed expectations by supporting others and providing effective assistance in various work experiences that foster growth and improvement.

She adopted the principles of strategic planning and development to create a positive impact in the community. With leadership experience and a strong work ethic, she is committed to executing creative plans aimed at driving sustainable growth through effective management and collaboration.

Over the past four years, she have developed various media management skills and have significant experience in representing the workplace. Additionally, she is always eager to learn and improve, with a strong ambition to acquire new skills.

Dr. Khalid Albarqi, a Pharm.D graduate from King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), 

He is currently serving as an inpatient pharmacist with a focus on sterile compounding and Total Parenteral Nutrition (TPN). 

His professional interests extend into the field of oncology, where he is actively engaged in exploring various topics and advancements. 

Additionally, Khalid has a strong research background, with a track record of published studies in critical care  oncology and ID, showcasing his dedication to advancing knowledge and practices within these specialized areas.